Clincosm LogoSign in Get a demo

Glioblastoma

Showing NaN - NaN of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Baltimore (Concurrent CRT Period, Post-CRT Period, Adjuvant Period)

Recruiting
  • Glioblastoma
  • Concurrent CRT Period
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Johns Hopkins Hospital
Mar 2, 2023

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

Recruiting
  • Diffuse Astrocytoma
  • +22 more
  • Phoenix, Arizona
  • +26 more
Jan 27, 2023

Brain Tumor Trial in Baltimore, Rochester (Exablate Model 4000)

Recruiting
  • Glioblastoma
  • +2 more
  • Focused Ultrasound (Exablate Model 4000)
  • Miami, Florida
  • +5 more
Jan 18, 2023

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Glioblastoma, Brain Tumor, Glioma Trial in United States (Procedure: LITT, Hypo-Fractionated Radiation Therapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Procedure: LITT
  • Hypo-Fractionated Radiation Therapy
  • Baltimore, Maryland
  • +3 more
Oct 10, 2022

Glioblastoma Trial in Australia, United States (drug, radiation, biological)

Completed
Has Results
  • Glioblastoma
  • Los Angeles, California
  • +7 more
Oct 3, 2022

Glioma, Glioblastoma Trial in United States (Focused ultrasound (FUS))

Active, not recruiting
  • Glioma
  • Glioblastoma
  • Focused ultrasound (FUS)
  • Baltimore, Maryland
  • +3 more
Sep 8, 2022

Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Costa Mesa, California
  • +49 more
Aug 24, 2022

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)

Recruiting
  • Glioblastoma
  • +5 more
  • Ipilimumab
  • +4 more
  • Birmingham, Alabama
  • +19 more
Aug 16, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Little Rock, Arkansas
  • +119 more
Aug 11, 2022

Glioma, Glioblastoma, Brain Tumor Trial in United States (LITT, Hypofractionated Radiation Therapy)

Recruiting
  • Glioma
  • +2 more
  • LITT
  • Hypofractionated Radiation Therapy
  • Baltimore, Maryland
  • +4 more
Apr 26, 2022

Glioblastoma, Gliosarcoma Trial in Miami, Atlanta, Baltimore (radiation, procedure, drug)

Active, not recruiting
  • Glioblastoma
  • Gliosarcoma
  • Dose-Escalated Radiation Therapy
  • +2 more
  • Miami, Florida
  • +2 more
Feb 16, 2022

Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)

Not yet recruiting
  • Glioblastoma
  • Baltimore, Maryland
    Johns Hopkins University
Dec 10, 2021

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
Has Results
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020

Glioblastoma, Glioblastoma Multiforme Trial in Baltimore (Nivolumab, Anti-GITR Monoclonal Antibody MK-4166, IDO1 inhibitor

Terminated
  • Glioblastoma
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jun 30, 2020

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in United States (Bevacizumab, Rindopepimut (CDX-110) with

Completed
  • Glioblastoma
  • +6 more
  • Birmingham, Alabama
  • +44 more
Feb 12, 2020

Glioblastoma Trial in Worldwide (enzastaurin, lomustine)

Completed
  • Glioblastoma
  • Phoenix, Arizona
  • +97 more
Sep 10, 2019

Glioblastoma, Astrocytoma, Grade IV Trial in Baltimore, New York (EGFR(V)-EDV-Dox)

Unknown status
  • Glioblastoma
  • Astrocytoma, Grade IV
  • Baltimore, Maryland
  • +1 more
Aug 27, 2019

Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,

Completed
Has Results
  • Glioblastoma
  • +2 more
  • 3-Dimensional Conformal Radiation Therapy
  • +6 more
  • Mobile, Alabama
  • +329 more
Jul 22, 2019

Glioblastoma Trial in Baltimore (Lymphocyte harvesting & reinfusion)

Completed
  • Glioblastoma
  • Lymphocyte harvesting & reinfusion
  • Baltimore, Maryland
    Johns Hopkins University
Nov 5, 2018

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,

Completed
  • Glioblastoma
  • +4 more
  • Rindopepimut (CDX-110) with GM-CSF
  • +2 more
  • Birmingham, Alabama
  • +222 more
Jan 11, 2018

Glioblastoma, Anaplastic Astrocytoma Trial in Baltimore (Fingolimod)

Completed
  • Glioblastoma
  • Anaplastic Astrocytoma
  • Baltimore, Maryland
    The Johns Hopkins University
Sep 12, 2017